[ALNY] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
31-Oct-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 4.99%
YoY- 14.98%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 103,962 99,476 71,681 70,061 44,714 33,294 21,033 190.45%
PBT -177,903 -181,646 -276,583 -208,929 -218,521 -181,220 -211,080 -10.78%
Tax 1,326 575 -398 -394 960 695 361 138.25%
NP -179,229 -182,221 -276,185 -208,535 -219,481 -181,915 -211,441 -10.44%
Tax Rate - - - - - - - -
Total Cost 283,191 281,697 347,866 278,596 264,195 215,209 232,474 14.07%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -172.40 -183.18 -385.30 -297.65 -490.86 -546.39 -1,005.28 -69.16%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -1.56 -1.62 -2.47 -1.92 -2.02 -1.73 -2.09 -17.73%
EPS Diluted -1.56 -1.62 -2.47 -1.92 -2.02 -1.73 -2.09 -17.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.